{"entity":{"type":"insider","cik":"0001369453","url":"/insider/0001369453","json_url":"/insider/0001369453.json","name":"Wentworth Kerry","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":20,"first":"2009-06-29","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Wentworth Kerry","source":"filing","n_filings":20,"first_seen":"2009-06-29","last_seen":"2026-06-24"}],"transactions":[{"id":5777104,"accession":"0001369453-26-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001369453-26-000008","line_url":"/filing/0001369453-26-000008#line-2","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (CHIEF REGULATORY OFFICER)","officer_title":"CHIEF REGULATORY OFFICER","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63000.0,"shares_display":"63,000","price_per_share":6.0189,"price_display":"6.02","price_state":"stated","total_value":379190.7,"total_display":"379,190.70","shares_owned_after":53000.0,"shares_owned_after_display":"53,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider"},{"id":5833443,"accession":"0001369453-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001369453-26-000006","line_url":"/filing/0001369453-26-000006#line-2","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (CHIEF REGULATORY OFFICER)","officer_title":"CHIEF REGULATORY OFFICER","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36750.0,"shares_display":"36,750","price_per_share":5.0144,"price_display":"5.01","price_state":"stated","total_value":184279.2,"total_display":"184,279.20","shares_owned_after":53000.0,"shares_owned_after_display":"53,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-17","filed_date":"2026-04-21","scope":"insider"},{"id":6052864,"accession":"0001369453-26-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001369453-26-000005","line_url":"/filing/0001369453-26-000005#line-3","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (CHIEF REGULATORY OFFICER)","officer_title":"CHIEF REGULATORY OFFICER","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":4.5178,"price_display":"4.52","price_state":"stated","total_value":903560.0,"total_display":"903,560.00","shares_owned_after":53000.0,"shares_owned_after_display":"53,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-08","scope":"insider"},{"id":5125298,"accession":"0001415889-25-017657","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-017657","line_url":"/filing/0001415889-25-017657#line-2","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (CHIEF REGULATORY OFFICER)","officer_title":"CHIEF REGULATORY OFFICER","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":1.79,"price_display":"1.79","price_state":"stated","total_value":46540.0,"total_display":"46,540.00","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":5125293,"accession":"0001415889-25-017657","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-017657","line_url":"/filing/0001415889-25-017657#line-1","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Nuvation Bio Inc.","issuer_ticker":"NUVB","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (CHIEF REGULATORY OFFICER)","officer_title":"CHIEF REGULATORY OFFICER","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24000.0,"shares_display":"24,000","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":43200.0,"total_display":"43,200.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":5162667,"accession":"0001209191-21-047504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-047504","line_url":"/filing/0001209191-21-047504#line-1","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (Chief Regulatory Officer)","officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3944.0,"shares_display":"3,944","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":25438.8,"total_display":"25,438.80","shares_owned_after":140362.0,"shares_owned_after_display":"140,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-20","scope":"insider"},{"id":5543875,"accession":"0001209191-21-002565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-002565","line_url":"/filing/0001209191-21-002565#line-1","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (Chief Regulatory Officer)","officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6829.0,"shares_display":"6,829","price_per_share":11.13,"price_display":"11.13","price_state":"stated","total_value":76006.77,"total_display":"76,006.77","shares_owned_after":113767.0,"shares_owned_after_display":"113,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-07","scope":"insider"},{"id":2624460,"accession":"0001209191-20-002283","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002283","line_url":"/filing/0001209191-20-002283#line-1","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (Chief Regulatory Officer)","officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3724.0,"shares_display":"3,724","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":50061.0,"shares_owned_after_display":"50,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-07","scope":"insider"},{"id":7920123,"accession":"0001209191-19-002084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-002084","line_url":"/filing/0001209191-19-002084#line-1","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"Flexion Therapeutics Inc","issuer_ticker":"FLXN","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (Chief Regulatory Officer)","officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":622.0,"shares_display":"622","price_per_share":12.36,"price_display":"12.36","price_state":"stated","total_value":7687.92,"total_display":"7,687.92","shares_owned_after":11207.0,"shares_owned_after_display":"11,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":7084168,"accession":"0001288123-14-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-14-000016","line_url":"/filing/0001288123-14-000016#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg & Qual)","officer_title":"VP, Clinical, Reg & Qual","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","shares_owned_after":57410.0,"shares_owned_after_display":"57,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-26","filed_date":"2014-02-28","scope":"insider"},{"id":9163502,"accession":"0001288123-11-000099","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001288123-11-000099","line_url":"/filing/0001288123-11-000099#line-3","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg, & Quality)","officer_title":"VP, Clinical, Reg, & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8939.0,"shares_display":"8,939","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":17967.39,"total_display":"17,967.39","shares_owned_after":15478.0,"shares_owned_after_display":"15,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-29","filed_date":"2011-12-29","scope":"insider"},{"id":9163501,"accession":"0001288123-11-000099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-11-000099","line_url":"/filing/0001288123-11-000099#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg, & Quality)","officer_title":"VP, Clinical, Reg, & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1893.0,"shares_display":"1,893","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":3956.37,"total_display":"3,956.37","shares_owned_after":24417.0,"shares_owned_after_display":"24,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-28","filed_date":"2011-12-29","scope":"insider"},{"id":9163500,"accession":"0001288123-11-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-11-000099","line_url":"/filing/0001288123-11-000099#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg, & Quality)","officer_title":"VP, Clinical, Reg, & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3156.0,"shares_display":"3,156","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":6753.84,"total_display":"6,753.84","shares_owned_after":26309.0,"shares_owned_after_display":"26,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-27","filed_date":"2011-12-29","scope":"insider"},{"id":9094009,"accession":"0001288123-11-000094","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001288123-11-000094","line_url":"/filing/0001288123-11-000094#line-3","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg, & Quality)","officer_title":"VP, Clinical, Reg, & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":886.0,"shares_display":"886","price_per_share":2.1973,"price_display":"2.20","price_state":"stated","total_value":1946.8078,"total_display":"1,946.81","shares_owned_after":29465.0,"shares_owned_after_display":"29,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-23","filed_date":"2011-12-23","scope":"insider"},{"id":9094008,"accession":"0001288123-11-000094","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-11-000094","line_url":"/filing/0001288123-11-000094#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg, & Quality)","officer_title":"VP, Clinical, Reg, & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1716.0,"shares_display":"1,716","price_per_share":2.1903,"price_display":"2.19","price_state":"stated","total_value":3758.5548,"total_display":"3,758.55","shares_owned_after":30351.0,"shares_owned_after_display":"30,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-22","filed_date":"2011-12-23","scope":"insider"},{"id":9094007,"accession":"0001288123-11-000094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-11-000094","line_url":"/filing/0001288123-11-000094#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"AGENUS INC","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clinical, Reg, & Quality)","officer_title":"VP, Clinical, Reg, & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3414.0,"shares_display":"3,414","price_per_share":2.238,"price_display":"2.24","price_state":"stated","total_value":7640.532,"total_display":"7,640.53","shares_owned_after":32067.0,"shares_owned_after_display":"32,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-21","filed_date":"2011-12-23","scope":"insider"},{"id":7594554,"accession":"0001288123-10-000074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000074","line_url":"/filing/0001288123-10-000074#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin, Reg & Quality)","officer_title":"VP, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4165.0,"shares_display":"4,165","price_per_share":0.97,"price_display":"0.97","price_state":"stated","total_value":4040.05,"total_display":"4,040.05","shares_owned_after":144088.0,"shares_owned_after_display":"144,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-26","filed_date":"2010-10-28","scope":"insider"},{"id":7166666,"accession":"0001288123-10-000065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000065","line_url":"/filing/0001288123-10-000065#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (Vp, Clin, Reg & Quality)","officer_title":"Vp, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1453.0,"shares_display":"1,453","price_per_share":0.9051,"price_display":"0.91","price_state":"stated","total_value":1315.1103,"total_display":"1,315.11","shares_owned_after":144088.0,"shares_owned_after_display":"144,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-14","filed_date":"2010-09-14","scope":"insider"},{"id":7395105,"accession":"0001288123-10-000058","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000058","line_url":"/filing/0001288123-10-000058#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin, Reg & Quality)","officer_title":"VP, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4165.0,"shares_display":"4,165","price_per_share":0.7995,"price_display":"0.80","price_state":"stated","total_value":3329.9175,"total_display":"3,329.92","shares_owned_after":140541.0,"shares_owned_after_display":"140,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-26","filed_date":"2010-07-28","scope":"insider"},{"id":7652398,"accession":"0001288123-10-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000032","line_url":"/filing/0001288123-10-000032#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin, Reg & Quality)","officer_title":"VP, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4165.0,"shares_display":"4,165","price_per_share":1.2146,"price_display":"1.21","price_state":"stated","total_value":5058.809,"total_display":"5,058.81","shares_owned_after":140539.0,"shares_owned_after_display":"140,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-26","filed_date":"2010-04-28","scope":"insider"},{"id":9281839,"accession":"0001288123-10-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-10-000012","line_url":"/filing/0001288123-10-000012#line-1","is_derivative":false,"issuer_cik":"0001369453","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001369453","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin, Reg & Quality)","officer_title":"VP, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102316.0,"shares_display":"102,316","price_per_share":0.8534,"price_display":"0.85","price_state":"stated","total_value":87316.4744,"total_display":"87,316.47","shares_owned_after":140537.0,"shares_owned_after_display":"140,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-20","filed_date":"2010-01-22","scope":"insider"},{"id":7652392,"accession":"0001288123-10-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-10-000008","line_url":"/filing/0001288123-10-000008#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin, Reg & Quality)","officer_title":"VP, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":102316.0,"shares_display":"102,316","price_per_share":0.8534,"price_display":"0.85","price_state":"stated","total_value":87316.4744,"total_display":"87,316.47","shares_owned_after":140537.0,"shares_owned_after_display":"140,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-20","filed_date":"2010-01-21","scope":"insider"},{"id":5589857,"accession":"0001288123-09-000056","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-09-000056","line_url":"/filing/0001288123-09-000056#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin, Reg & Quality)","officer_title":"VP, Clin, Reg & Quality","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1367.0,"shares_display":"1,367","price_per_share":2.323,"price_display":"2.32","price_state":"stated","total_value":3175.541,"total_display":"3,175.54","shares_owned_after":106432.0,"shares_owned_after_display":"106,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-11","filed_date":"2009-09-14","scope":"insider"},{"id":5633963,"accession":"0001288123-09-000050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001288123-09-000050","line_url":"/filing/0001288123-09-000050#line-3","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin., Reg. & Qual)","officer_title":"VP, Clin., Reg. & Qual.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20302.0,"shares_display":"20,302","price_per_share":1.618,"price_display":"1.62","price_state":"stated","total_value":32848.636,"total_display":"32,848.64","shares_owned_after":102799.0,"shares_owned_after_display":"102,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-16","filed_date":"2009-07-17","scope":"insider"},{"id":5633962,"accession":"0001288123-09-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001288123-09-000050","line_url":"/filing/0001288123-09-000050#line-2","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin., Reg. & Qual)","officer_title":"VP, Clin., Reg. & Qual.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13271.0,"shares_display":"13,271","price_per_share":1.763,"price_display":"1.76","price_state":"stated","total_value":23396.773,"total_display":"23,396.77","shares_owned_after":123101.0,"shares_owned_after_display":"123,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-15","filed_date":"2009-07-17","scope":"insider"},{"id":5600103,"accession":"0001288123-09-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001288123-09-000040","line_url":"/filing/0001288123-09-000040#line-1","is_derivative":false,"issuer_cik":"0001098972","issuer_name":"ANTIGENICS INC /DE/","issuer_ticker":"AGEN","issuer_name_source":null,"issuer_url":"/issuer/0001098972","owner_cik":"0001369453","owner_name":"Wentworth Kerry","owner_url":"/insider/0001369453","role":"Officer (VP, Clin., Reg. and Qual)","officer_title":"VP, Clin., Reg. and Qual.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":49250.0,"total_display":"49,250.00","shares_owned_after":21172.0,"shares_owned_after_display":"21,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-06-25","filed_date":"2009-06-29","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001811063","name":"Nuvation Bio Inc.","url":"/issuer/0001811063","role":"Officer (CHIEF REGULATORY OFFICER)","n_filings":4,"first_seen":"2025-06-18","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001419600","name":"Flexion Therapeutics Inc","url":"/issuer/0001419600","role":"Officer (Chief Regulatory Officer)","n_filings":4,"first_seen":"2019-01-04","last_seen":"2021-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001098972","name":"AGENUS INC","url":"/issuer/0001098972","role":"Officer (VP, Clinical, Reg & Qual)","n_filings":12,"first_seen":"2009-06-29","last_seen":"2014-02-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001369453","retrieved_at":"2026-08-21T11:22:30+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}